Status:
COMPLETED
Long-term Study of TAK-875
Lead Sponsor:
Takeda
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with TAK-875 in diabetic patients.
Eligibility Criteria
Inclusion
- The participant is an outpatient.
- The participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
Exclusion
- The participant has any serious cardiac disease, serious cerebrovascular disorder, or any serious pancreatic or hematological disease.
- The participant is considered ineligible for the study for any other reason by the investigator or sub-investigator.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
1222 Patients enrolled
Trial Details
Trial ID
NCT01433406
Start Date
October 1 2011
End Date
December 1 2013
Last Update
January 27 2014
Active Locations (71)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya, Aichi-ken, Japan
2
Chiba, Chiba, Japan
3
Funabashi-shi, Chiba, Japan
4
Katori-shi, Chiba, Japan